TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 5 | 0 | 4 | -12 | -46 | -97 | -106 | -51 |
S | %wins | 40 | 20 | 60 | 80 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/15 16:38 | 4/6/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Zsebo Krisztina M | CA | DO | CEO | S.d | -872 | 18.20 | 33 | -48 | -94 | 3 | D | 83 | 73 | -12 | 5 | -33 | -18 | -6 | -4 | 3 | -89 | -95 | -97 | ||
3/9/15 21:03 | 3/9/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Zsebo Krisztina M | CA | DO | CEO | S.d | -1,189 | 24.80 | 12 | -48 | -94 | 3 | D | 108 | 140 | 87 | 41 | 46 | 34 | 28 | 2 | 8 | -28 | -94 | -99 | ||
2/10/15 18:15 | 2/9/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Zsebo Krisztina M | CA | DO | CEO | S.d | -760 | 15.86 | 3 | -48 | -94 | 3 | D | 108 | 44 | 35 | -18 | -11 | -12 | 0 | 5 | 4 | 65 | -85 | -94 | ||
1/8/15 18:43 | 1/6/15 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Zsebo Krisztina M | CA | DO | CEO | S.d | -723 | 17.51 | 7 | -41 | -93 | 3 | D | 13 | 80 | 47 | -3 | -10 | -14 | 6 | 5 | -9 | -3 | -94 | |||
12/10/14 19:07 | 12/9/14 | CLDN | Celladon Corp | DE | Health | BioPrd | Biological Products, (No Diag | Zsebo Krisztina M | CA | DO | CEO | S.d | -620 | 15.00 | 2 | -41 | -96 | 2 | D | 49 | 48 | 52 | 37 | 29 | 27 | -9 | -2 | 3 | 48 | -100 | -106 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |